A Brisbane woman’s bowel cancer diagnosis following a routine screening test at a Springfield-based hospital has highlighted concerns over low participation in Australia’s national bowel screening program.
Early Detection at Springfield Lakes Raises Broader Health Concerns
Charlotte Hassing, a Brisbane resident, underwent a free bowel cancer screening after her general practitioner issued a test kit due to low iron levels and ongoing fatigue. Despite having no noticeable symptoms, the test detected hidden blood in her stool, which later led to a confirmed cancer diagnosis following a colonoscopy at Mater Private Hospital Springfield.

National Program Sees Low Uptake
According to the Australian Institute of Health and Welfare’s most recent monitoring report, over 60 per cent of eligible participants between 2021 and 2022 did not complete their free screening kits. Out of approximately six million people invited, only 40 per cent participated.
Of those who returned a positive test result in 2022, only 13.5 per cent received a follow-up colonoscopy within the recommended 30-day period. Wait times for colonoscopy services varied significantly depending on location, with delays ranging from 133 to 197 days.
Mater Specialist Highlights Urgency of Early Screening
Dr Sylvia Vigh, a gastroenterologist at Mater Private Hospital Springfield and Mater Private Hospital Brisbane, emphasised that bowel cancer often progresses without visible symptoms. She noted that by the time common signs—such as visible blood in stool, abdominal pain, fatigue, or weight loss—appear, the disease may already be advanced.
Data shows that 90 per cent of stage one bowel cancer cases can be successfully treated if diagnosed early. However, reduced follow-up rates and prolonged wait times could impact treatment outcomes.
Policy Change Expands Screening Age Range
To address increasing cases among younger Australians, eligibility for the National Bowel Cancer Screening Program was recently expanded. As of 1 July 2024, individuals aged 45 to 49 may opt in to receive a free screening kit every two years. This adjustment responds to a concerning trend, with one in nine new bowel cancer cases now occurring in people under 50.
Since the program’s introduction in 2006, more than 11.4 million kits have been completed, with approximately 4.8 million people participating at least once.

Uncertainty Remains for Patients
Charlotte Hassing’s condition was found to be hereditary and is currently being treated with immunotherapy, which has shown better effectiveness in her case than traditional chemotherapy. While her treatment continues, she said the psychological strain of waiting and uncertainty has been more difficult than the treatment itself.
Published 10-July-2025